Why HLN fell on Oct 29
Down 14% on Oct 29, and still 10% under its Oct 28 close.
- Haleon fell 14% that day while personal care stocks rose a median 1%:
Down 14% on Oct 29, and still 10% under its Oct 28 close.
HLN's Quality Score rose 1 point on Tue, Nov 10, to 2. It closed near its high of the day (2 chart checks started).
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
| Holding it back | Below a falling 200-day average |
| Latest filing | 20-F, Mar 13 |
Sensodyne maker Haleon cuts revenue growth forecast on weak flu season, China disruption
HLN closed −14.3% that day on 3.4x normal volume.
After its last 2 reports it closed -3.7% on average, higher 0 of 2 times.
Below Averagefor quality, not price, 3 of 14 chart checks firingWhat the Quality Score means
HLN is #8 of 8 by Quality Score.
| Rank | Stock | Quality Score |
|---|---|---|
| 1 | ||
| 2 | ||
| 3 | ||
| Open for its score | ||
| Open for its score | ||
| 8 |
Expected to report Thu Feb 25, before the open (in 107 days).
What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.
| Reported | Gap | Reaction | 5 days |
|---|---|---|---|
| Jul 30, 2026 | -1.5% | -1.6% | -3.2% |
| Feb 25, 2026 | -7.0% | -5.8% | -4.2% |
Sales grew in two of the last five years, to £11B in 2025. It made a profit in each of the six years.
RSI 43.5, MACD below signal, below both averages. Not scored.
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.
HLN scores 2 today, which Breakaway calls Below Average. It is #8 of 8 in Perfumes, Cosmetics & Other Toilet Preparations by Quality Score, with 3 of 14 chart checks firing. Down 14% on Oct 29, and still 10% under its Oct 28 close. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.
HLN scores 2 today, which Breakaway calls Below Average (0 to 5). That is #8 of 8 in Perfumes, Cosmetics & Other Toilet Preparations by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind HLN's 2.
Expected to report Thu Feb 25, before the open, a date Breakaway expects from the company's usual timing; the company has not confirmed it. HLN closed higher after 0 of its last 2 reports. Past behavior, not a forecast.
Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.
Insider and Congress trades, the chart, and the financials, in one score.
See it live, free until Thursday morning. No account. No card. Then keep going with a free account.